✨ Pharmaceutical and Laboratory Schedule Amendments
19 DECEMBER
NEW ZEALAND GAZETTE
4217
b) where such costs are identifiable, the payment is an amount equal to those costs; or
c) where such costs are not identifiable, the payment is an amount that reflects a fair and reasonable reimbursement of the General Practitioner’s costs, having regard to the supply of items such as labour, premises and consumables and to any other payments made by the Ministry of Health or District Health Board or Patients for the collection and/or transportation of samples;
provided that the payment for collection and/or transportation:
d) is on a ‘per Patient’ and not a ‘per sample’ basis;
e) is only for actions, in relation to the collection of samples, which a laboratory service provider would ordinarily carry out if the General Practitioner did not do so;
f) is not for actions which the General Practitioner would ordinarily carry out, and which could be covered by a separate payment for those services, such as the completion of a referral form;
g) is only to cover services reasonably provided by the General Practitioner to the extent that such services are not already funded by the Ministry of Health, such as services covered by the Practice Nurse subsidy;
h) does not result in the General Practitioner in any other way profiting excessively from providing the collection and/or transportation.
"19.7 For the avoidance of doubt, the ability to audit the General Practitioner and any records or other information under this Notice includes audit for the purpose of verifying compliance with the obligations of the General Practitioner under this clause.
"19.8 If the General Practitioner (or any person connected to that General Practitioner) is in receipt of any incentive or inducement from a laboratory at the date that this variation comes into effect, no payment will be withheld if the incentive or inducement has been removed or has ceased to be an incentive or inducement by reason of payment or otherwise equivalent to the incentive or inducement (any such payment being by the General Practitioner, or connected Persons, as applicable) within three months from the date that this variation comes into effect.
"19.9 If the General Practitioner (or any person connected to that General Practitioner) accepts any incentive or inducement from a laboratory service provider, either directly or indirectly, that General Practitioner will reimburse to the District Health Board the amount of any such incentive or inducement and indemnify the District Health Board and the Ministry of Health for any loss caused by that General Practitioner’s actions, including payment of costs relating to audit, investigation and legal services, as applicable. The District Health Board will provide the General Practitioner with a reasonable opportunity to comment on any allegation that the General Practitioner has received an incentive or inducement before exercising or enforcing its rights under this clause.
"20 Identification of Payer
"20.1 All prescription and laboratory referral forms completed by the General Practitioner must identify the payer in respect of those services, where the payer is not the District Health Board (or the Ministry of Health).
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2001, No 172
Gazette.govt.nz —
NZ Gazette 2001, No 172
✨ LLM interpretation of page content
🏥
Amendments to Pharmaceutical and Laboratory Schedules
(continued from previous page)
🏥 Health & Social WelfarePharmaceutical Schedule, Laboratory Schedule, Payment Agent, Eligible People, Prohibition, Incentives, General Practitioners